Tumor growth of the human U87 glioblastoma cells as xenografts on nude mice is delayed by treatment with monoclonal antibodies against human YKL-40 [197], suggesting that YKL-40 may be a potential cancer target. The gene discussed is CHI3L1; the disease is cancer.